Rare diseases
Investigational molecules
Locations
Avinguda De La Gran Via De L'hospitalet 199, 08908 L'hospitalet De Llobregat, Spain
Solid tumours are a major focus, including advanced solid tumours, germ cell tumours, metastatic uveal melanoma, and cutaneous squamous cell carcinoma. The portfolio also includes studies in tumour immune resistance and anti-PD-1 therapy.
Research activity in this area includes cell-based immunotherapy, tumour response assessment, and the study of biomarkers linked to treatment resistance.
Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL runs clinical trials in conditions such as Renal transplant, Diabetes prophylaxis, Pyelonephritis, Germ cell cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
